Clinical Trial Update: TMC (Topotecan, Cyclophosphamide and Melphalan) for Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating TMC (topotecan, cyclophosphamide, and melphalan) for multiple myeloma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• TMC (topotecan, cyclophosphamide and melphalan) (topotecan, cyclophosphamide, and melphalan)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Myeloma | Phase 2 | Status: COMPLETED